Skip Nav Destination

Issue Archive

Select Year

Issue

Inhibition of NADPH oxidase blocks NETosis and reduces thrombosis in heparin-induced thrombocytopenia

Halina H. L. Leung,Jose Perdomo,Zohra Ahmadi,Feng Yan,Steven E. McKenzie,Beng H. Chong

View Article

Supplemental data

NUDT15 variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia
Clinical Trials & Observations

View Article

Supplemental data

ASH Research Collaborative: a real-world data infrastructure to support real-world evidence development and learning healthcare systems in hematology

William A. Wood,Peter Marks,Robert M. Plovnick,Kathleen Hewitt,Donna S. Neuberg,Sam Walters,Brendan K. Dolan,Emily A. Tucker,Charles S. Abrams,Alexis A. Thompson,Kenneth C. Anderson,Paul Kluetz,Ann Farrell,Donna Rivera,Matthew Gertzog,Gregory Pappas

View Article

Supplemental data

BLOOD ADVANCES TALK

Investigational curative gene therapy approaches to sickle cell disease
Clinical Trials & Observations

David A. Williams,Erica Esrick

View Article

Supplemental data

EXCEPTIONAL CASE REPORT

Stuttering priapism in a patient with sickle cell trait treated with automated red cell exchange transfusion

Mohammad S. Ebraheem,Madeleine Verhovsek

View Article

STIMULUS REPORT

CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes
Clinical Trials & Observations

View Article

Supplemental data

Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in acute myeloid leukemia

Megan E. Zavorka Thomas,Jae Yoon Jeon,Zahra Talebi,Daelynn R. Buelow,Josie Silvaroli,Moray J. Campbell,Alex Sparreboom,Navjot Pabla,Sharyn D. Baker

View Article

Supplemental data

Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia

View Article

Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma

Niklas Gebauer,Hanno M. Witte,Hartmut Merz,Ilske Oschlies,Wolfram Klapper,Almuth Caliebe,Lars Tharun,Malte Spielmann,Nikolas von Bubnoff,Alfred C. Feller,Eva M. Murga Penas

View Article

Supplemental data

Combined ibrutinib and venetoclax treatment vs single agents in the TCL1 mouse model of chronic lymphocytic leukemia

Arnon P. Kater,Erik Slinger,Gaspard Cretenet,Anne W. Martens,Sriram Balasubramanian,Joel D. Leverson,Eric Eldering

View Article

Supplemental data

Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience
Clinical Trials & Observations

Guillaume Richard-Carpentier,Hagop M. Kantarjian,Guilin Tang,C. Cameron Yin,Joseph D. Khoury,Ghayas C. Issa,Fadi Haddad,Nitin Jain,Farhad Ravandi,Nicholas J. Short,Courtney D. DiNardo,Koichi Takahashi,Marina Y. Konopleva,Naval G. Daver,Tapan Kadia,Guillermo Garcia-Manero,Rebecca Garris,Susan O’Brien,Elias Jabbour

View Article

SYSTEMATIC REVIEW

Bleeding assessment tools in the diagnosis of VWD in adults and children: a systematic review and meta-analysis of test accuracy

View Article

Supplemental data

CLINICAL TRIALS AND OBSERVATIONS

Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant
Clinical Trials & Observations

Dai Chihara,Evgeny Arons,Maryalice Stetler-Stevenson,Constance Yuan,Hao-Wei Wang,Hong Zhou,Mark Raffeld,Liqiang Xi,Seth M. Steinberg,Julie Feurtado,Lacey James-Echenique,Chin-Hsien Tai,Keyur P. Patel,Raul C. Braylan,Katherine R. Calvo,Irina Maric,Alina Dulau-Florea,Robert J. Kreitman

View Article

Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel
Clinical Trials & Observations

View Article

Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma
Clinical Trials & Observations

View Article

Supplemental data

Economic evaluation of regular transfusions for cerebral infarct recurrence in the Silent Cerebral Infarct Transfusion Trial
Clinical Trials & Observations

Peter Hsu,James C. Gay,Chyongchiou J. Lin,Mark Rodeghier,Michael R. DeBaun,Robert M. Cronin

View Article

Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma
Clinical Trials & Observations

Kristine A. Frerichs,Monique C. Minnema,Mark-David Levin,Annemiek Broijl,Gerard M. J. Bos,Marie José Kersten,Tuna Mutis,Christie P. M. Verkleij,Inger S. Nijhof,Patricia W. C. Maas-Bosman,Saskia K. Klein,Sonja Zweegman,Pieter Sonneveld,Niels W. C. J. van de Donk

View Article

Supplemental data

Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML
Clinical Trials & Observations

View Article

Supplemental data

Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies
Clinical Trials & Observations

View Article

Supplemental data

HEALTH SERVICES AND OUTCOMES

Indirect comparison of tisagenlecleucel and blinatumomab in pediatric relapsed/refractory acute lymphoblastic leukemia

Michael R. Verneris,Qiufei Ma,Jie Zhang,Amy Keating,Ranjan Tiwari,Junlong Li,Hongbo Yang,Abhijit Agarwal,Lida Pacaud

View Article

HEMATOPOIESIS AND STEM CELLS

Hapln1b, a central organizer of the ECM, modulates kit signaling to control developmental hematopoiesis in zebrafish

Christopher B. Mahony,Pietro Cacialli,Corentin Pasche,Rui Monteiro,Savvas N. Savvides,Julien Y. Bertrand

View Article

Supplemental data

Redundant mechanisms driven independently by RUNX1 and GATA2 for hematopoietic development

Erica Bresciani,Blake Carrington,Kai Yu,Erika M. Kim,Tao Zhen,Victoria Sanchez Guzman,Elizabeth Broadbridge,Kevin Bishop,Martha Kirby,Ursula Harper,Stephen Wincovitch,Stefania Dell’Orso,Vittorio Sartorelli,Raman Sood,Paul Liu

View Article

Supplemental data

CXCL12-abundant reticular cells are the major source of IL-6 upon LPS stimulation and thereby regulate hematopoiesis

Rahel C. Gerosa,Steffen Boettcher,Larisa V. Kovtonyuk,Annika Hausmann,Wolf-Dietrich Hardt,Juan Hidalgo,César Nombela-Arrieta,Markus G. Manz

View Article

Supplemental data

Genome-wide whole-blood transcriptome profiling across inherited bone marrow failure subtypes

Amanda J. Walne,Tom Vulliamy,Findlay Bewicke-Copley,Jun Wang,Jenna Alnajar,Maria G. Bridger,Bernard Ma,Hemanth Tummala,Inderjeet Dokal

View Article

Supplemental data

IMMUNOBIOLOGY AND IMMUNOTHERAPY

An autologous culture model of nodal B-cell lymphoma identifies ex vivo determinants of response to bispecific antibodies

Tobias Roider,Berit J. Brinkmann,Vladislav Kim,Mareike Knoll,Carolin Kolb,Philipp M. Roessner,Marie Bordas,Peter Dreger,Carsten Müller-Tidow,Wolfgang Huber,Martina Seiffert,Sascha Dietrich

View Article

Supplemental data

Human iPSC-derived macrophages for efficient Staphylococcus aureus clearance in a murine pulmonary infection model

Anna Rafiei Hashtchin,Beate Fehlhaber,Miriam Hetzel,Felix Manstein,Jan Lennart Stalp,Silke Glage,Markus Abeln,Robert Zweigerdt,Antje Munder,Dorothee Viemann,Mania Ackermann,Nico Lachmann

View Article

Supplemental data

Humoral immune reconstitution after anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma
Clinical Trials & Observations

View Article

Supplemental data

Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days
Clinical Trials & Observations

Lekha Mikkilineni,Bonnie Yates,Seth M. Steinberg,Shilpa A. Shahani,John C. Molina,Tara Palmore,Daniel W. Lee,Rosandra N. Kaplan,Crystal L. Mackall,Terry J. Fry,Juan Gea-Banacloche,Theresa Jerussi,Veronique Nussenblatt,James N. Kochenderfer,Nirali N. Shah

View Article

Supplemental data

LYMPHOID NEOPLASIA

Follicular lymphoma subgroups with and without t(14;18) differ in their N-glycosylation pattern and IGHV usage

Ellen Leich,Claudia Maier,Riccardo Bomben,Filippo Vit,Alessandro Bosi,Heike Horn,Valter Gattei,German Ott,Andreas Rosenwald,Alberto Zamò

View Article

Supplemental data

HGAL inhibits lymphoma dissemination by interacting with multiple cytoskeletal proteins

Xiaoyu Jiang,XiaoQing Lu,Andrew J. Gentles,Dekuang Zhao,Seth A. Wander,Yu Zhang,Yasodha Natkunam,Joyce Slingerland,Isildinha M. Reis,Brian Rabinovich,Midhat H. Abdulreda,Vincent T. Moy,Izidore S. Lossos

View Article

Supplemental data

Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician’s choice in cutaneous T-cell lymphoma: final data
Clinical Trials & Observations

View Article

Supplemental data

ALL blasts drive primary mesenchymal stromal cells to increase asparagine availability during asparaginase treatment

Martina Chiu,Giuseppe Taurino,Erica Dander,Donatella Bardelli,Alessandra Fallati,Roberta Andreoli,Massimiliano G. Bianchi,Cecilia Carubbi,Giulia Pozzi,Laura Galuppo,Prisco Mirandola,Carmelo Rizzari,Saverio Tardito,Andrea Biondi,Giovanna D’Amico,Ovidio Bussolati

View Article

Supplemental data

Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy
Clinical Trials & Observations

View Article

Supplemental data

Distinct clinical characteristics of DUX4- and PAX5-altered childhood B-lymphoblastic leukemia

Zhenhua Li,Shawn Hsien Ren Lee,Winnie Hui Ni Chin,Yi Lu,Nan Jiang,Evelyn Huizi Lim,Elaine Coustan-Smith,Kean Hui Chiew,Bernice Ling Zhi Oh,Grace Shimin Koh,Zhiwei Chen,Shirley Kow Yin Kham,Thuan Chong Quah,Hai Peng Lin,Ah Moy Tan,Hany Ariffin,Jun J. Yang,Allen Eng-Juh Yeoh

View Article

Supplemental data

Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma

View Article

Supplemental data

A novel 3D culture model recapitulates primary FL B-cell features and promotes their survival

View Article

Supplemental data

MYELOID NEOPLASIA

Engraftment characterization of risk-stratified AML in NSGS mice

View Article

Supplemental data

Defining the transcriptional control of pediatric AML highlights RARA as a superenhancer-regulated druggable dependency

Monika W. Perez,Oscar Sias-Garcia,Alfred Daramola,Helen Wei,Maci Terrell,Raushan Rashid,Woojun D. Park,Kevin Duong,Terzah M. Horton,Feng Li,Nikitha Cherayil,Jost Vrabic Koren,Vincent U. Gant,Jacob J. Junco,Choladda V. Curry,Alexandra M. Stevens,Charles Y. Lin,Joanna S. Yi

View Article

Supplemental data

Association of race and ethnicity with clinical phenotype, genetics, and survival in pediatric acute myeloid leukemia
Clinical Trials & Observations

Shannon E. Conneely,Casey L. McAtee,Rohit Gupta,Joseph Lubega,Michael E. Scheurer,Rachel E. Rau

View Article

Supplemental data

PD-1 inhibition in advanced myeloproliferative neoplasms

Gabriela Hobbs,Cansu Cimen Bozkus,Erin Moshier,Mikaela Dougherty,Michal Bar-Natan,Lonette Sandy,Kathryn Johnson,Julia Elise Foster,Tina Som,Molly Macrae,Hetal Marble,Mohamed Salama,Siraj M. El Jamal,Nicole Zubizarreta,Martha Wadleigh,Richard Stone,Nina Bhardwaj,Camelia Iancu-Rubin,John Mascarenhas

View Article

Supplemental data

ALCAM-EGFR interaction regulates myelomagenesis

View Article

Supplemental data

Anti-inflammatory treatment in MPN: targeting TNFR1 and TNFR2 in JAK2-V617F–induced disease

Peter Müller,Conny K. Baldauf,Tobias R. Haage,Ana M. Waldleben,Fabian Richter,Klaus Pfizenmaier,Thomas Fischer

View Article

Supplemental data

PLATELETS AND THROMBOPOIESIS

Platelet FcγRIIA-induced serotonin release exacerbates the severity of transfusion-related acute lung injury in mice

Marie-Belle El Mdawar,Blandine Maître,Stéphanie Magnenat,Florian Tupin,Friederike Jönsson,Christian Gachet,Henri de la Salle,Beatrice Hechler

View Article

Supplemental data

Bone marrow remodeling supports hematopoiesis in response to immune thrombocytopenia progression in mice

Oliver J. Herd,Gulab Fatima Rani,James P. Hewitson,Karen Hogg,Andrew P. Stone,Nichola Cooper,David G. Kent,Paul G. Genever,Ian S. Hitchcock

View Article

Supplemental data

Assessment of romiplostim immunogenicity in pediatric patients in clinical trials and in a global postmarketing registry

Charles Bowers,Daniel T. Mytych,Tatiana Lawrence,Kejia Wang,Troy E. Barger,Melissa Eisen,Carolyn M. Bennett,Michael D. Tarantino

View Article

Supplemental data

Ablation of collagen VI leads to the release of platelets with altered function

View Article

Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

The immunometabolite itaconate inhibits heme synthesis and remodels cellular metabolism in erythroid precursors

Jason R. Marcero,James E. Cox,Hector A. Bergonia,Amy E. Medlock,John D. Phillips,Harry A. Dailey, Jr

View Article

Supplemental data

Restriction of HIV-1 infection in sickle cell trait

View Article

Supplemental data

A community-centered approach to sickle cell disease and clinical trial participation: an evaluation of perceptions, facilitators, and barriers
Clinical Trials & Observations

LaTasha H. Lee,LaShanta H. Whisenton,Jasmine Benger,Sophie Lanzkron

View Article

Regulatory association of long noncoding RNAs and chromatin accessibility facilitates erythroid differentiation

Yunxiao Ren,Junwei Zhu,Yuanyuan Han,Pin Li,Jing Wu,Hongzhu Qu,Zhaojun Zhang,Xiangdong Fang

View Article

Supplemental data

THROMBOSIS AND HEMOSTASIS

Cleavage of talin by calpain promotes platelet-mediated fibrin clot contraction

Karen P. Fong,Kathleen S. Molnar,Nicholas Agard,Rustem I. Litvinov,Oleg V. Kim,James A. Wells,John W. Weisel,William F. DeGrado,Joel S. Bennett

View Article

Supplemental data

Differential sialic acid content in adult and neonatal fibrinogen mediates differences in clot polymerization dynamics

Kimberly Nellenbach,Alexander Kyu,Nina Guzzetta,Ashley C. Brown

View Article

Supplemental data

Stability of alteplase for ultrasound-facilitated catheter-directed thrombolysis

John Fanikos,Kathleen Marquis,Leo Buckley,Lena K. Tran,Kevin McLaughlin,Abby Jane Golash,Umberto Campia,Gregory Piazza,Jean M. Connors,Samuel Z. Goldhaber

View Article

TRANSPLANTATION

Predicting mortality from intracranial hemorrhage in patients who undergo allogeneic hematopoietic stem cell transplantation
Clinical Trials & Observations

View Article

Supplemental data

Type 1 interferon to prevent leukemia relapse after allogeneic transplantation
Clinical Trials & Observations

John M. Magenau,Dan Peltier,Mary Riwes,Attaphol Pawarode,Brian Parkin,Thomas Braun,Sarah Anand,Monalisa Ghosh,John Maciejewski,Gregory Yanik,Sung Won Choi,Moshe Talpaz,Pavan Reddy

View Article

Supplemental data

Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution
Clinical Trials & Observations

Katie Maurer,Haesook T. Kim,Thomas M. Kuczmarski,Heather M. Garrity,Augustine Weber,Carol G. Reynolds,Deborah Liney,Corey Cutler,Joseph H. Antin,John Koreth,Jerome Ritz,Roman M. Shapiro,Rizwan Romee,Catherine J. Wu,Robert J. Soiffer,Sarah Nikiforow,Vincent T. Ho,Mahasweta Gooptu

View Article

Supplemental data

Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma
Clinical Trials & Observations

View Article

Supplemental data

VASCULAR BIOLOGY

GDP/GTP exchange factor MADD drives activation and recruitment of secretory Rab GTPases to Weibel-Palade bodies

Marije Kat,Petra E. Bürgisser,Hans Janssen,Iris M. De Cuyper,Ianina L. Conte,Alistair N. Hume,Tom Carter,Jan Voorberg,Coert Margadant,Ruben Bierings

View Article

Supplemental data

RESEARCH LETTER

AVEXIS technology identifies novel platelet-leukocyte binding partners including CD148-CD300a

Ruben Barroso,Roy Bicknell,George Ed Rainger,Steve P. Watson,Yi Sun

View Article

Supplemental data

In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported

Tauangtham Anekpuritanang,Matthew M. Klairmont,Joel Gradowski,Kohei Hagiwara,Nathanael G. Bailey,Pranil Chandra,Yiwei Liu,Heather L. Mulder,John Easton,Jinghui Zhang,Michael G. Martin,Anna B. Owczarczyk,Jennifer B. Dunlap,Guang Fan,Richard D. Press,Philipp W. Raess

View Article

Supplemental data

Salvage radiotherapy is associated with durable response for a subset of patients with limited-stage refractory DLBCL
Clinical Trials & Observations

Jemima H. Miller,Michael Gilbertson,Michael P. MacManus,Andrew Wirth,Stephen S. Opat,Gareth P. Gregory

View Article

Supplemental data

Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia

David McCall,Michael Roth,Kris M. Mahadeo,Laurie Toepfer,Cesar Nunez,Nicholas J. Short,Naval Daver,Tapan M. Kadia,Courtney DiNardo,Joanna S. Yi,Branko Cuglievan

View Article

Macrophage activation syndrome-like (MAS-L) manifestations following BCMA-directed CAR T cells in multiple myeloma

Vanessa E. Kennedy,Christopher Wong,Chiung-Yu Huang,Swetha Kambhampati,Jeffrey Wolf,Thomas G. Martin,Nina Shah,Sandy W. Wong

View Article

Supplemental data

Cover Image

Cover Image

Confocal fluorescence microscopy image of Cxcl12DsRed/+ reporter mouse bone marrow after 4 weeks of passive immune thrombocytopenia. Chronic platelet depletion increased expression of Cxcl12 (red) and blood vessel surface area (laminin, green). The increase in Cxcl12 was transient, but the increase in blood vessel surface area persisted for at least 4 weeks after recovery. See the article by Herd et al.
Front Matter
Editorial Board

Issue Archive

Table of Contents

NUDT15 variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia Clinical Trials & Observations

BLOOD ADVANCES TALK

Investigational curative gene therapy approaches to sickle cell disease Clinical Trials & Observations

EXCEPTIONAL CASE REPORT

STIMULUS REPORT

CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes Clinical Trials & Observations

Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience Clinical Trials & Observations

SYSTEMATIC REVIEW

CLINICAL TRIALS AND OBSERVATIONS

Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant Clinical Trials & Observations

Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel Clinical Trials & Observations

Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma Clinical Trials & Observations

Economic evaluation of regular transfusions for cerebral infarct recurrence in the Silent Cerebral Infarct Transfusion Trial Clinical Trials & Observations

Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma Clinical Trials & Observations

Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML Clinical Trials & Observations

Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies Clinical Trials & Observations

HEALTH SERVICES AND OUTCOMES

HEMATOPOIESIS AND STEM CELLS

IMMUNOBIOLOGY AND IMMUNOTHERAPY

Humoral immune reconstitution after anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma Clinical Trials & Observations

Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days Clinical Trials & Observations

LYMPHOID NEOPLASIA

Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician’s choice in cutaneous T-cell lymphoma: final data Clinical Trials & Observations

Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy Clinical Trials & Observations

MYELOID NEOPLASIA

Association of race and ethnicity with clinical phenotype, genetics, and survival in pediatric acute myeloid leukemia Clinical Trials & Observations

PLATELETS AND THROMBOPOIESIS

RED CELLS, IRON, AND ERYTHROPOIESIS

A community-centered approach to sickle cell disease and clinical trial participation: an evaluation of perceptions, facilitators, and barriers Clinical Trials & Observations

THROMBOSIS AND HEMOSTASIS

TRANSPLANTATION

Predicting mortality from intracranial hemorrhage in patients who undergo allogeneic hematopoietic stem cell transplantation Clinical Trials & Observations

Type 1 interferon to prevent leukemia relapse after allogeneic transplantation Clinical Trials & Observations

Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution Clinical Trials & Observations

Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma Clinical Trials & Observations

VASCULAR BIOLOGY

RESEARCH LETTER

Salvage radiotherapy is associated with durable response for a subset of patients with limited-stage refractory DLBCL Clinical Trials & Observations

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only

NUDT15 variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia
Clinical Trials & Observations

Investigational curative gene therapy approaches to sickle cell disease
Clinical Trials & Observations

CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes
Clinical Trials & Observations

Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience
Clinical Trials & Observations

Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant
Clinical Trials & Observations

Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel
Clinical Trials & Observations

Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma
Clinical Trials & Observations

Economic evaluation of regular transfusions for cerebral infarct recurrence in the Silent Cerebral Infarct Transfusion Trial
Clinical Trials & Observations

Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma
Clinical Trials & Observations

Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML
Clinical Trials & Observations

Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies
Clinical Trials & Observations

Humoral immune reconstitution after anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma
Clinical Trials & Observations

Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days
Clinical Trials & Observations

Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician’s choice in cutaneous T-cell lymphoma: final data
Clinical Trials & Observations

Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy
Clinical Trials & Observations

Association of race and ethnicity with clinical phenotype, genetics, and survival in pediatric acute myeloid leukemia
Clinical Trials & Observations

A community-centered approach to sickle cell disease and clinical trial participation: an evaluation of perceptions, facilitators, and barriers
Clinical Trials & Observations

Predicting mortality from intracranial hemorrhage in patients who undergo allogeneic hematopoietic stem cell transplantation
Clinical Trials & Observations

Type 1 interferon to prevent leukemia relapse after allogeneic transplantation
Clinical Trials & Observations

Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution
Clinical Trials & Observations

Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma
Clinical Trials & Observations

Salvage radiotherapy is associated with durable response for a subset of patients with limited-stage refractory DLBCL
Clinical Trials & Observations